Scientific program
The Symposium will include Plenary Lectures, Oral, and Poster Presentations on:
| Program sessions | Organizer |
|---|---|
| Analytical Chemistry | Ki Hyun Kim (Sungkyunkwan University) |
| Cancer | Seoung Hyun Oh (Gachon Unversity) |
| Cardiovascular and Metabolic Diseases | Jong-Hoon Kim (Jeonbuk National University) |
| Cultivation & Genomics | Tae-Jin Yang (Seoul National University) |
| Endocrinology/Infertility | YoungJoo Lee (Sejong University) |
| History of Ginseng | Jeong Hill Park (Seoul National University) |
| Immunomodulation (adjuvant) | Jae Youl Cho (Sungkyunkwan University) |
| Infectious Diseases | Dong-Kwon Rhee (Sungkyunkwan University) |
| Neurological disorder | Seikwan Oh (Ewha Womans University) |
| Non-saponin Pharmacology | Seung-Yeol Nah (Konkuk University) |
| Skin and Dermatology | Su-Nam Kim (KIST) |
| Translational Pharmacology | Sung Dae Kim (Kyungpook National University) |
| Young Scientist | Man Hee Rhee (Kyungpook National University) |
DAY 1 - Wednesday, October 26, 2022 (Room A)
| Time | Program | Chair | |
|---|---|---|---|
| 09:30~10:00 | Opening Ceremony / Group Photo | ||
| 10:30~12:15 | Session 1. Infectious diseases | ||
| 10:30 | PL01 | Animal models for SARS-CoV-2 infection and their application for vaccines and therapeutics Young-Ki Choi (Chungbuk National University, Republic of Korea) |
Dong-Kwon Rhee (Sungkyunkwan University, Republic of Korea) |
| 11:00 | OP01 | Inhibitory effect of Korean ginseng on COVID-19 virus infection in animal models Mi Kyung Pyo (Geumsan Ginseng and Herb Development Agency, Republic of Korea) |
|
| 11:15 | OP02 | Nanodisc-based virucidals for influenza virus and SARS-CoV-2 Dae-Hyuk Kweon (Sungkyunkwan University, Republic of Korea) |
|
| 11:30 | OP03 | Korean ginseng attenuates lobar pneumonia and potentiates immunity Dong-Kwon Rhee (Sungkyunkwan University, Republic of Korea) |
|
| 11:45 | OP04 | Korean Red Ginseng treatment delays coreceptor tropism switch in HIV-1 infection over 30 years Young-Keol Cho (University of Ulsan College of Medicine, Republic of Korea) |
|
| 12:00 | OP05 | Biological Effects of Korean Red Ginseng on Senecent Immune Cells Yong Yook Lee (Korea Ginseng Corporation, Republic of Korea) |
|
| 12:15~13:30 | Lunch | ||
| 13:30~15:15 | Session 2. Immunomodulation (adjuvant) | ||
| 13:30 | PL02 | Ginseng is helpful for maintaining immunity gained by Vaccination against COVID-19: Prospective cohort study Dong-Hyuk Jung (Yongin Severance Hospital, Republic of Korea) |
Jae Youl Cho (Sungkyunkwan University, Republic of Korea) |
| 14:00 | OP06 | Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the anti-tumor effect of anti-programmed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy Elaine Leung (Macau University of Science and Technology, Macau) |
|
| 14:15 | OP07 | Role of Neutrophils in AECOPD and Protective Effect of Ginsenoside Rg3 Fang Wang (Jilin University, China) |
|
| 14:30 | OP08 | Anti-inflammatory effect of Korean red ginseng and its mechanism Jae Youl Cho (Sungkyunkwan University, Republic of Korea) |
|
| 14:45 | OP09 | Contrasting regulation of inflammasomes depending on ingredients of Korean Red Ginseng Geun-Shik Lee (Kangwon National University, Republic of Korea) |
|
| 15:00 | OP10 | Ginsenoside Rg3 acts as anti-atherosclerosis drug via suppressing inflammatory responses Yu Tao (Qingdao University, China) |
|
| 15:15~15:30 | Coffee Break | ||
| 13:30~15:15 | Session 3. Cancer | ||
| 15:30 | PL03 | Ginseng on cancer: From animal studies to clinical trials Chun-Su Yuan (University of Chicago, USA) |
Seung Hyun Oh (Gachon University, Republic of Korea) |
| 16:00 | OP11 | Identification of cellular targets of rare ginsenosides and its acting mechanism in liver cancer cells Ying-Hua Jin (Jilin University, China) |
|
| 16:15 | OP12 | 20(S)-Ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo Haibo Zhang (Henan University of Chinese Medicine, China) |
|
| 16:30 | OP13 | Ginsenoside Rh1 inhibit luminal/HER-2 breast cancer migration by targeting FGF21-SENP2 signaling pathway Tianshi Wang (Shanghai Jiao Tong University, China) |
|
| 16:45 | OP14 | The tumor-suppressive effect of ginsenosides in mitosis Chang-Young Jang (Sookmyung Women's University, Republic of Korea) |
|
| 17:00~18:30 | Poster Presentation | ||
| 18:30~20:30 | Welcome Party | ||
DAY 1 - Wednesday, October 26, 2022 (Room B)
| Time | Program | Chair | |
|---|---|---|---|
| 09:30~10:00 | Opening Ceremony / Group Photo | ||
| 10:30~12:30 | Session 4. Neurological disorder | ||
| 10:30 | PL04 | Ameliorating effects of Korea red ginseng on the neuronal diseases Seikwan Oh (Ewha Womans University, Republic of Korea) |
Seikwan Oh (Ewha Womans University, Republic of Korea) |
| 11:00 | OP15 | Effects of Red ginseng extract on alcohol-induced addictive disorders in rodents Choon-Gon Jang (Sungkyunkwan University, Republic of Korea) |
|
| 11:15 | OP16 | Antidepressant and hypnotic effects of ginsenoside-Rg1 Yong-He Zhang (Peking University, China) |
|
| 11:30 | OP17 | Red ginseng attenuates antipsychotic-induced extrapyramidal symptoms and cognitive dysfunction Jong Hoon Ryu (Kyung Hee University, Republic of Korea) |
|
| 11:45 | OP18 | Ginseng inhibits fibrosis in age-related macular degeneration via modulation of crystallin alpha B Jaesuk Yun (Chungbuk National University, Republic of Korea) |
|
| 12:00 | OP19 | Neuroprotective effect of Panax ginseng as an actoprotector Sergiy Olinyk (Kyiv National Medical University, Ukraine) |
|
| 12:15~13:30 | Lunch | ||
| 13:30~15:15 | Session 5. Cardiovascular and Metabolic Diseases | ||
| 13:30 | OP20 | Preferential regulation of lipid metabolism by Korean red ginseng Y. Eugene Chin (Suzhou University, China) |
Jong-Hoon Kim (Jeonbuk National University, Republic of Korea) |
| 13:45 | OP21 | Mitochondrial connection to ginsenosides by regulation of inflammasome signaling Yoon-Seok Roh (Chungbuk National University, Republic of Korea) |
|
| 14:00 | OP22 | Application of Ginseng compound K incorporated biomaterial porous scaffold in bone tissue engineering Muthukumar Thangavelu (LinkoCare Life Sciences Ltd., Sweden) |
|
| 14:15 | OP23 | Anti-thrombotic effects of ginsenoside Rk1 from Korea Red Ginseng through regulation of platelet activity Dong-Ha Lee (Namseoul University, Republic of Korea) |
|
| 14:30 | OP24 | Protective effects of ginsenoside Rb1 against osteoarthritis in menopausal rats Adithan Aravinthan (University of South Florida, USA) |
|
| 14:45 | OP25 | Potential adaptogenic effects of Panax ginseng and its ginsenosides on modulation of cardiovascular functions Muhammad Irfan (University of Illinois Chicago, USA) |
|
| 15:00 | OP26 | The chondroprotective effect of ginsenoside-Rb1 against bone injury via MAPK down-regulation Amjad Hossain (Jeonbuk National University, Republic of Korea) |
|
| 15:15~15:30 | Coffee Break | ||
| 15:30~16:45 | Session 6. History of Ginseng | ||
| 15:30 | PL05 | A History of the Korean Ginseng Industry Il Moo Chang (Seoul National University, Republic of Korea) |
Jeong Hill Park (Seoul National University, Republic of Korea) |
| 16:00 | OP27 | The Multiple World Systems of Ginseng: A Trade History Heasim Sul (Yonsei University, Republic of Korea) |
|
| 16:15 | OP28 | The Past, Present and Future of Vietnamese Ginseng Truong Huy Nguyen (Ton Duc Thang University, Vietnam) |
|
| 16:30 | OP29 | Emperor Minh Mang, Minh Mang Thang and Korean Ginseng Thi Hong Van Le (University of Medicine & Pharmacy HCMC, Vietnam) |
|
| 17:00~18:30 | Poster Presentation | ||
| 18:30~20:30 | Welcome Party | ||
